Palvella Therapeutics
UEI: KTH1B7KWRCN9
• CAGE: 8AT89
Overview
Awardee Type
Parent
Company Description
Palvella Therapeutics is committed to developing safe and effective therapies that specifically target the root cause of genetic skin diseases.
Name
Palvella Therapeutics
Website
Headquarters
Wayne, PA
United States
United States
Most Recent Award
Sept. 20, 2024
Calculating
Federal grant recipient
PALVELLA THERAPEUTICS, INC.
(UEI KTH1B7KWRCN9, CAGE 8AT89)
is headquartered in Wayne PA.
The corporation
was founded in September 2015 and
federally registered in
April 2019.
Federal Award Analysis
Palvella Therapeutics federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
PALVELLA THERAPEUTICS, INC.
UEI
KTH1B7KWRCN9
CAGE Code
8AT89
Primary NAICS
None Reported
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Assistance Awards
Date Founded
Sept. 11, 2015
Initial Registration
April 12, 2019
Last Registration
Jan. 9, 2025
Registration Activation
Jan. 7, 2025
Registration Expiration
Jan. 3, 2026
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
Not Available
Reported NAICS
None Reported
Accepts Credit Cards
No